Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 7 | BES2004 | Next issue

23rd Joint Meeting of the British Endocrine Societies with the European Federation of Endocrine Societies

Symposia

Joint BES and EFES symposium: Neuroactive steroids: implications for disease and healthy ageing

ea0007s31 | Joint BES and EFES symposium: Neuroactive steroids: implications for disease and healthy ageing | BES2004

Effects of neuroactive steroids on myelination

Melcangi R , Ballabio M , Gonzalez L , Gyenes C , Leonelli E , Magnaghi V

It is now well known that peripheral nervous system (PNS) is able to synthesize neurosteroids and to convert them, or hormonal steroids coming from the periphery, in neuroactive steroids. Moreover, PNS possess both classical (e.g., progesterone receptor, PR, androgen receptor, AR) and non-classical (e.g., GABAA receptor) steroid receptors and consequently may represent a target for the action of neuroactive steroids. Our data have indicated that neuroactive steroids, like for ...

ea0007s32 | Joint BES and EFES symposium: Neuroactive steroids: implications for disease and healthy ageing | BES2004

Glial cells as mediators of the neuroprotective effects of oestrogen in the central nervous system

Garcia-Segura L , Veiga S , Mendez P , Garcia-Ovejero D , DonCarlos L , Azcoitia I

Endogenous as well as exogenous androgens and oestrogen have neuroprotective properties. Oestrogen is formed locally in neural tissue from precursor androgens. In the brain, the expression of aromatase, the enzyme that catalyses the conversion of androgens to oestrogen, is restricted, under normal circumstances, to specific neuronal populations involved in neuroendocrine control and in the modulation of reproductive or sexually dimorphic behaviours. However, the expression of ...

ea0007s33 | Joint BES and EFES symposium: Neuroactive steroids: implications for disease and healthy ageing | BES2004

Oestrogen and stroke: the potential for harm as well as benefit

Macrae I

The hormone oestrogen is reported to be the most widely prescribed drug worldwide through its use in the contraceptive pill and in hormone replacement therapy (HRT). Oestrogen and HRT has been widely prescribed for prevention of osteoporosis and relief of menopausal symptoms. However, as women age, their risk of stroke and heart disease also increases, particularly after the menopause. The effects of oestrogen on stroke risk and on the ischaemic brain are complex and still not...

ea0007s34 | Joint BES and EFES symposium: Neuroactive steroids: implications for disease and healthy ageing | BES2004

Sexual dimorphism and neuroprotection by sex steroids in an animal model of Parkinson's disease

Gillies G , Murray H , Dexter D , McArthur S

Epidemiological and clinical studies provide evidence for sex differences in the incidence or severity of certain neurological conditions. For example Parkinson's disease, which is characterised by a progressive degeneration of dopaminergic (DA) neurones in the substantia nigra pars compacta (SNc) and a reduction in DA levels in the striatum, is more prevalent in men than women. Therefore, our work aimed to establish whether physiological levels of sex steroid hormones confer ...